as on January 8, 2026 at 4:01 pm IST
Day's Low
Day's High
0.58%
Downside
3.57%
Upside
52 Week's Low
52 Week's High
12.78%
Downside
48.30%
Upside
as on January 8, 2026 at 4:01 pm IST
Market Cap
₹608.24 Cr
Return on Equity (ROE)
11.02
PE Ratio (TTM)
20.75
Return on capital employed (ROCE)
13.14
Industry PE ratio
42.5
Beta (LTM)
0.96
P/B Ratio
2.3
Dividend Yield
0PEG Ratio
3.09
Quarterly Earnings Growth YOY
-6.62
EPS (TTM)
15.178352987229
Sector
Pharmaceuticals
Book Value
123.12
Technical Analysis
Bearish
View Technical Analysis
as on January 8, 2026 at 4:01 pm IST
Kilitch Drugs in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (20.75x)
January 7, 2026
Industry (42.50x)
January 7, 2026
Highest (371.68x)
October 16, 2020
Today’s Price to Earnings Ratio: 20.75x
Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 608.24 | 53.87% | 0.60 | 24 | 198 | |
| NA | 121.96 | 36.64% | 0.00 | 13 | 100 | |
| NA | 94.41 | 180.37% | 0.00 | 8 | 64 | |
| NA | 400.28 | 23.73% | 0.68 | 18 | 344 | |
| NA | 18.23 | 129.18% | 0.00 | NA | 6 |
Get share price movements and forecasts by analysts on Kilitch Drugs.
Source: S&P Global Market Intelligence
Search interest for Kilitch Drugs (India) Ltd Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Kilitch Drugs.
Kilitch Drugs (India) Ltd’s net profit fell -4.99% since last year same period to ₹8.19Cr in the Q2 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 170.3% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.14%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 45.7 Cr → 55.58 Cr (in ₹), with an average increase of 17.8% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 3.03 Cr → 8.19 Cr (in ₹), with an average increase of 63.0% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 30.76% to 36.23% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.1% return, outperforming this stock by 24.2%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.1% return, outperforming this stock by 35.8%
Price Dip
![]()
In the last 7 days, KILITCH stock has moved down by -3.2%
Promoter Holding Down
![]()
Promoters have decreased holdings from 69.23% to 63.77% in Sep 2025 quarter
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Mukund P Mehta |
| E-voting on shares | Click here to vote |
Kilitch Drugs share price today stands at ₹337.15 as on at the close of the market. Kilitch Drugs share today touched a day high of ₹349.2 and a low of ₹335.2.
Kilitch Drugs touched a 52 week high of ₹500 and a 52 week low of ₹294.07. Kilitch Drugs share price today i.e. is closed at ₹337.15, which is -32.57% down from its 52 week high and 14.65% up from its 52 week low.
Kilitch Drugs market capitalisation is ₹608.24 Cr as on .
To buy Kilitch Drugs shares, you need to follow these steps:
Kilitch Drugs trading volume is 5,948.00 as on . This means that 5,948.00 shares of Kilitch Drugs were bought and sold on the stock market during today's trading session.